Skip to main content

Hambleton Julie

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Hambleton Julie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

SWTX SpringWorks Therapeutics, Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 12, 2025 (view filing)Feb 102 daysHambleton JulieDirectorSSale−13.8K$53.01−$730.2K−77.1%4.09K after10b5-1
Jun 5, 2024 (view filing)Jun 32 daysHambleton JulieDirectorSSale−4.65K$40.03−$186.0K−53.2%4.09K after4 lots10b5-1
Jul 21, 2023 (view filing)Jul 192 daysHambleton JulieDirectorSSale−2.42K$29.31−$70.9K−34.2%4.65K after10b5-1
Jun 22, 2023 (view filing)Jun 202 daysHambleton JulieDirectorSSale−2.40K$26.92−$64.6K−25.4%7.07K after10b5-1
Mar 16, 2023 (view filing)Mar 151 dayHambleton JulieDirectorSSale−1.11K$31.50−$34.8K−18.7%4.82K after

IGMS IGM Biosciences, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 29, 2024 (view filing)Jul 254 daysHambleton JulieDirectorSSale−15.1K$14.00−$211.8K−88.3%2.00K after10b5-1
Aug 11, 2021 (view filing)Aug 92 daysHambleton JulieDirectorSSale−1.00K$80.00−$80.0K−33.3%2.00K after

ERAS Erasca, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 20, 2021 (view filing)Jul 20Same dayHambleton JulieDirectorPPurchase+6.00K$16.00+$96.0KNew position6.00K after